The shares of Citrix Systems, Inc. (NASDAQ:CTXS) has been pegged with a rating of Buy by Deutsche Bank in its latest research note that was published on June 6th, 2019. Deutsche Bank wasn’t the only research firm that published a report of Citrix Systems, Inc., with other equities research analysts also giving their opinion on the stock. BofA/Merrill advised investors in its research note published on October 25th, 2018, to Neutral the CTXS stock while also putting a $116 price target. The stock had earned Neutral rating from Wedbush when it published its report on October 19th, 2018. That day the Wedbush set price target on the stock to $115. The stock was given Hold rating by Stifel in its report released on July 26th, 2018, the day when the price target on the stock was placed at $120. Robert W. Baird was of a view that CTXS is Neutral in its latest report on July 20th, 2018. Berenberg thinks that CTXS is worth Hold rating. This was contained in the firm’s report on April 26th, 2018.
Amongst the analysts that rated the stock, 1 have recommended investors to sell it, 10 believe it has the potential for further growth, thus rating it as Hold while 4 advised investors to purchase the stock. The consensus currently stands at a Hold while its average price target is $109.07. The price of the stock the last time has raised by 2.24% from its Week high price while it is raised higher than its 52-Week low price. A look at the stock’s other technical shows that its 14-day RSI now stands at 35.42.
The shares of the company added by 1.18% during the trading session on Tuesday, reaching a low of $90.57 while ending the day at $92.30. During the trading session, a total of 2.27 million shares were traded which represents a -13.32% decline from the average session volume which is 2.00M shares. CTXS had ended its last session trading at 91.22. Citrix Systems, Inc. currently has a market cap of $12.14B, while its P/E ratio stands at 26.20, while its P/E earnings growth sits at 4.04, with a beta of 1.02. Citrix Systems, Inc. debt-to-equity ratio currently stands at 3.44, while its quick ratio hovers at 0.90. CTXS 52-week low price stands at $90.28 while its 52-week high price is $114.55.
The company in its last quarterly report recorded $1.21 earnings per share which is below the $1.34 predicted by most analysts. The Citrix Systems, Inc. generated $748.70 million in revenue during the last quarter, which is slightly lower than the $769.22 million predicted by analysts. In the second quarter last year, the firm recorded $1.27 earnings per share. Compared to the same quarter last year, the firm’s revenue was down by -4.96%. Citrix Systems, Inc. has the potential to record 3.52 EPS for the current fiscal year, according to equities analysts.
Investment analysts at Morgan Stanley published a research note on June 12th, 2019 where it informed investors and clients that Coca-Cola European Partners plc (NYSE:CCEP) is now rated as Equal-Weight. BofA/Merrill also rated CCEP as Reiterated on October 25th, 2018, with its price target of $116 suggesting that CCEP could surge by 5.33% from its current share price. Even though the stock has been trading at $55.17/share, analysts expect it to surge higher by -1.47% to reach $57.42/share. It started the day trading at $54.99 and traded between $53.85 and $54.36 throughout the trading session.
A look at its technical shows that CCEP’s 50-day SMA is 56.69 while its 200-day SMA stands at 51.04. The stock has a high of $58.35 for the year while the low is $41.64. The company’s P/E ratio currently sits at 26.99, while the P/B ratio is 3.58. At the moment, only of Coca-Cola European Partners plc shares were sold short. The company’s average trading volume currently stands at 1.16M shares, which means that the short-interest ratio is just 3.24 days. Over the past seven days, the company moved, with its shift of -0.84%. Looking further, the stock has dropped -1.40% over the past 90 days while it gained 14.51% over the last six months.
The change in the stock’s fortunes has led to several institutional investors altering their holdings of the stock. Capital Research Management Co sold more CCEP shares, decreasing its portfolio by -2.83% during the last quarter. This move now sees Capital Research Management Co selling -926,270 shares in the last quarter, thus it now holds 31,797,374 shares of CCEP, with a total valuation of $1,757,758,835. BlackRock Fund Advisors meanwhile sold more CCEP shares in the recently filed quarter, changing its stake to $362,709,438 worth of shares. Boston Partners Global Investors followed the path by decreasing its CCEP portfolio by -38.70% in the quarter. This means that Boston Partners Global Investors sold -3,760,407 shares in the last quarter and now controls 5,956,978 shares of the CCEP stock, with the valuation hitting $329,301,744.
Similarly, Fidelity Management Research Co decreased its Coca-Cola European Partners plc shares by -8.92% during the recently filed quarter. After selling -414,961 shares in the last quarter, the firm now controls 4,234,501 shares of Coca-Cola European Partners plc which are valued at $234,083,215. In the same vein, SSgA Funds Management Inc increased its Coca-Cola European Partners plc shares by during the most recent reported quarter. The firm bought 1,038,388 shares during the quarter which increased its stakes to 3,756,684 shares and is now valued at $207,669,492. Following these latest developments, around of Coca-Cola European Partners plc stocks are owned by institutional investors and hedge funds.